Rehabilitation - Physical Activity and Coping (RPAC)

February 27, 2024 updated by: Haukeland University Hospital

The project is a non-randomized intervention study with group-based physical exercise. Cancer survivors who have participated in the rehabilitation program at the Center for Education and Rehabilitation are included in the study.

The cancer and cancer treatment have led to patients struggling with physical, mental and social late effects which prevent them from functioning in everyday life and return to work. The purpose of the project is to investigate whether one municipal group training measure can help to lower the threshold for the user to maintain good exercise habits and return to work / everyday life, as well as the effect on the user's physical form and quality of life and the transition between health level and the body itself measure.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bergen, Norway, 5021
        • Helse Bergen,

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18 years
  • Women and men
  • Regardless of cancer diagnosis
  • Resident in Bergen municipality
  • Finishes their rehabilitation at The Cancer Center for Education and Rehabilitation spring/summer 2019.

Exclusion Criteria:

  • Patients who do not speak or understand Norwegian
  • Unable to express themselves in writing
  • Unable to perform basic daily tasks
  • Display cognitive disorder or severe emotional instability
  • Suffer from other debilitating illnesses / conditions that may inhibit physical exercise (heart failure, chronic obstructive pulmonary disease, orthopedic conditions, neurological disorders or the like) will be excluded from the study. -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise
18 weeks supervised strength and aerobic exercise training
18 weeks supervised strength and aerobic exercise training.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Objectively recorded physical activity level
Time Frame: 18 weeks
Change in objectively recorded physical activity level, measured with the SenseWear ™ Mini Armband (SWA) (BodyMedia Inc. Pittsburgh, PA, USA) as average minutes of moderate- to vigorous intensity physical activity (MVPA) from before intervention to after completion of the intervention.
18 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in maximal oxygen uptake measured by VO2max
Time Frame: 18 weeks
Change in VO2max, measured by a maximal incremental exercise test on a treadmill, from before training intervention to post training intervention.
18 weeks
Change in maximal strength
Time Frame: 18 weeks
Change in 1 repetition maximum strength in upper and lower body measured from before intervention and after completion of the intervention.
18 weeks
Change in quality of life measured by Short Form Health Survey (SF-36)
Time Frame: 18 weeks
Change in scores on the Short Form Health Survey (SF-36) from before intervention to after completion of the intervention.
18 weeks
Change in fatigue scores using the Chalder Fatigue Questionaire (FQ)
Time Frame: 18 weeks
Change in scores on the Chalder Fatigue Questionaire (FQ) from before intervention to after completion of the intervention.
18 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Cecilia Arving, PhD, Helse Bergen, Cancer Center for Education and Rehabilitation

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 22, 2019

Primary Completion (Actual)

August 26, 2019

Study Completion (Estimated)

October 31, 2024

Study Registration Dates

First Submitted

January 16, 2020

First Submitted That Met QC Criteria

January 26, 2020

First Posted (Actual)

January 29, 2020

Study Record Updates

Last Update Posted (Estimated)

February 28, 2024

Last Update Submitted That Met QC Criteria

February 27, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2019/620

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All individual participant data (IPD) that underlie results in a publication are to be shared with two master students and their professors/supervisors/researchers who take part in the study.

IPD Sharing Time Frame

The data will become available from February 2020 to October 31. 2024

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer Survivors

Clinical Trials on Exercise training

Subscribe